Role of HIF-induced EMT in invasion and metastasis of tumor;HIF 诱导 EMT 在肿瘤侵袭转移中的作用

Journal of Central South University (Medical Sciences)

Volumn 41, Issue 8, 2016, Pages 872-878

  Chen, Yang ^a   Shi, Yan ^a   Dai, Guanghai ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Epithelial to mesenchymal transition; Hypoxia inducible factor; Invasion; Metastasis; Tumor

Indexed keywords

BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; BETA CATENIN; CTNNB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA;

EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; METASTASIS; NEOPLASM; TUMOR INVASION;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BETA CATENIN; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA;

EID: 85016433301     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: 10.11817/J.ISSN.1672-7347.2016.08.017     Document Type: Review

References (59)

1. Jiang J, Tang YL, Liang XH. EMT: a new vision of hypoxia promoting cancer progression[J]. Cancer Biol Ther, 2011, 11(8): 714-723.
2. Greco O, Marples B, Joiner MC, et al. How to overcome(and exploit) tumor hypoxia for targeted gene therapy[J]. J Cell Physiol, 2003, 197(3): 312-325.
3. Wartenberg M, Gronczynska S, Bekhite MM, et al. Regulation of the multidrug resistance transporter P-glycoprotein in multicellular prostate tumor spheroids by hyperthermia and reactive oxygen species[J]. Int J Cancer, 2005, 113(2): 229-240.
4. Semenza GL. Targeting Hif-1 for cancer therapy[J]. Nat Rev Cancer 2003, 3(10): 721-732.
5. Huchet A, Fernandez P, Allard M, et al. [Molecular imaging of tumor hypoxia][J]. Cancer Radiother, 2009, 13(8): 747-757.
6. Schofield CJ, Ratcliffe PJ. Oxygen sensing by HIF hydroxylases[J]. Nat Rev Mol Cell Biol, 2004, 5(5): 343-354.
7. Semenza GL. HIF-1, O(2), and the 3 PHDs: how animal cells signal hypoxia to the nucleus[J]. Cell, 2001, 107(1): 1-3.
8. Wenger RH, Stiehl DP, Camenisch G. Integration of oxygen signaling at the consensus HRE[J]. Sci STKE, 2005, 2005(306): re12.
9. Baldewijns MM, van Vlodrop IJ, Vermeulen PB, et al. VHL and HIF signalling in renal cell carcinogenesis[J]. J Pathol, 2010, 221(2): 125-138.
10. Semenza GL. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics[J]. Oncogene, 2010, 29(5): 625-634.
11. Blagosklonny MV, An WG, Romanova LY, et al. p53 inhibits hypoxia-inducible factor-stimulated transcription[J]. J Biol Chem, 1998, 273(20): 11995-11998.
12. Ravi R, Mookerjee B, Bhujwalla ZM, et al. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha[J]. Genes Dev, 2000, 14(1): 34-44.
13. Zundel W, Schindler C, Haas-Kogan D, et al. Loss of PTEN facilitates HIF-1-mediated gene expression[J]. Genes Dev, 2000, 14(4): 391-396.
14. Denko NC. Hypoxia, HIF1 and glucose metabolism in the solid tumour[J]. Nat Rev Cancer, 2008, 8(9): 705-713.
15. 郝希山. 肿瘤学[M]. 2版. 北京: 人民卫生出版社, 2014: 89-90. Hao Xishan. Oncology[M]. 2nd ed. Beijing: People's Medical Publishing House, 2014: 89-90.
16. Schneider BP, Sledge GW Jr. Drug insight: VEGF as a therapeutic target for breast cancer[J]. Nat Clin Pract Oncol, 2007, 4(3): 181-189.
17. Liang X, Yang D, Hu J, et al. Hypoxia inducible factor-alpha expression correlates with vascular endothelial growth factor-C expression and lymphangiogenesis/angiogenesis in oral squamous cell carcinoma[J]. Anticancer Res, 2008, 28(3A): 1659-1666.
18. Wang SY, Ke YQ, Lu GH, et al. Vasculogenic mimicry is a prognostic factor for postoperative survival in patients with glioblastoma[J]. J Neurooncol, 2013, 112(3): 339-345.
19. Birner P, Schindl M, Obermair A, et al. Expression of hypoxia-inducible factor 1alpha in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy[J]. Clin Cancer Res, 2001, 7(6): 1661-1668.
20. Koukourakis MI, Giatromanolaki A, Skarlatos J, et al. Hypoxia inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy[J]. Cancer Res, 2001, 61(5): 1830-1832.
21. Volm M, Koomägi R. Hypoxia-inducible factor(HIF-1) and its relationship to apoptosis and proliferation in lung cancer[J]. Anticancer Res, 2000, 20(3A): 1527-1533.
22. Li J, Shi M, Cao Y, et al. Knockdown of hypoxia-inducible factor-1alpha in breast carcinoma MCF-7 cells results in reduced tumor growth and increased sensitivity to methotrexate[J]. Biochem Biophys Res Commun, 2006, 342(4): 1341-1351.
23. Wartenberg M, Gronczynska S, Bekhite MM, et al. Regulation of the multidrug resistance transporter P-glycoprotein in multicellular prostate tumor spheroids by hyperthermia and reactive oxygen species[J]. Int J Cancer, 2005, 113(2): 229-240.
24. Minakata K, Takahashi F, Nara T, et al. Hypoxia induces gefitinib resistance in non-small-cell lung cancer with both mutant and wild-type epidermal growth factor receptors[J]. Cancer Sci, 2012, 103(11): 1946-1954.
25. Liang Y, Zheng T, Song R, et al. Hypoxia-mediated sorafenib resistance can be overcome by EF24 through VHL-dependent HIF-1α inhibition in hepatocellular carcinoma [J]. Hepatology, 2013, 57(5):1847-1857.
26. Pennacchietti S, Michieli P, Galluzzo M, et al. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene[J]. Cancer Cell, 2003, 3(4): 347-361.
27. Muñoz-Nájar UM, Neurath KM, Vumbaca F, et al. Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation[J]. Oncogene, 2006, 25(16): 2379-2392.
28. Krishnamachary B, Berg-Dixon S, Kelly B, et al. Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1[J]. Cancer Res, 2003, 63(5): 1138-1143.
29. Choi SH, Shin HW, Park JY, et al. Effects of the knockdown of hypoxia inducible factor-1α expression by adenovirus-mediated shRNA on angiogenesis and tumor growth in hepatocellular carcinoma cell lines[J]. Korean J Hepatol. 2010; 16(3):280-287.
30. Du R, Huang C, Bi Q, et al. URG11 mediates hypoxia-induced epithelial-to-mesenchymal transition by modulation of E-cadherin and beta-catenin[J]. Biochem Biophys Res Commun, 2010, 391(1): 135-141.
31. Marie-Egyptienne DT, Lohse I, Hill RP. Cancer stem cells, the epithelial to mesenchymal transition(EMT) and radioresistance: potential role of hypoxia[J]. Cancer Lett, 2013, 341(1): 63-72.
32. Acloque H, Adams MS, Fishwick K, et al. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease[J]. J Clin Invest, 2009, 119(6): 1438-1449.
33. Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits[J]. Nat Rev Cancer, 2009, 9(4): 265-273.
34. Thiery JP, Sleeman JP. Complex networks orchestrate epithelial-mesenchymal transitions[J]. Nat Rev Mol Cell Biol, 2006, 7(2): 131-142.
35. Matsuo N, Shiraha H, Fujikawa T, et al. Twist expression promotes migration and invasion in hepatocellular carcinoma[J]. BMC Cancer, 2009, 9: 240.
36. Valdés-Mora F, Gómez del Pulgar T, Bandrés E, et al. TWIST1 overexpression is associated with nodal invasion and male sex in primary colorectal cancer[J]. Ann Surg Oncol, 2009, 16(1): 78-87.
37. Willis BC, Liebler JM, Luby-Phelps K, et al. Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis[J]. Am J Pathol, 2005, 166(5): 1321-1332.
38. Rafael D, Doktorovová S, Florindo HF, et al. EMT blockage strategies: Targeting Akt dependent mechanisms for breast cancer metastatic behaviour modulation[J], Curr Gene Ther, 2015, 15(3): 300-312.
39. 刘丽华, 代勤, 闵志刚, 等. 转化生长因子β1通过ERK/MAPK信号转导通路促进脑胶质瘤细胞侵袭[J]. 南方医科大学学报, 2013, 33(12): 1744-1747. LIU Lihua, DAI Qin, MIN Zhigang, et al. Transforming growth factorβ1 enhances the invasiveness of human glioma cell line via ERK/MAPK pathway[J]. Journal of Southern Medical University, 2013, 33(12): 1744-1747.
40. Copple BL. Hypoxia stimulates hepatocyte epithelial to mesenchymal transition by hypoxia-inducible factor and transforming growth factor-beta-dependent mechanisms[J]. Liver Int, 2010, 30(5): 669-682.
41. Javelaud D, Mauviel A. Crosstalk mechanisms between the mitogenactivated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis[J]. Oncogene, 2005, 24(37): 5742-5750.
42. Sahlgren C, Gustafsson MV, Jin S, et al. Notch signaling mediates hypoxia-induced tumor cell migration and invasion[J]. Proc Natl Acad Sci USA, 2008, 105(17): 6392-6397.
43. Zheng X, Linke S, Dias JM, et al. Interaction with factor inhibiting HIF-1 defines an additional mode of cross-coupling between the Notch and hypoxia signaling pathways[J]. Proc Natl Acad Sci USA, 2008, 105(9): 3368-3373.
44. Zhang Q, Bai X, Chen W, et al. Wnt/β-catenin signaling enhances hypoxia- induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1α signaling[J]. Carcinogenesis, 2013, 34(5): 962-973.
45. 谢强, 黄作平, 闫雍容, 等. MiR-221 调控 PTEN/Akt 信号介导人胶质瘤耐药细胞上皮间质转化相关基因的表达[J]. 南方医科大学学报, 2014, 34(2): 218-222. XIE Qiang, HUANG Zuoping, YAN Yongrong, et al. MiR-221 mediates epithelial-mesenchymal transition-related gene expressions via regulation of PTEN/Akt signaling in drug-resistant glioma cells[J]. Journal of Southern Medical University, 2014, 34(2): 218-222.
46. Ying Q, Liang L, Guo W, et al. Hypoxia-inducible microRNA-210 augments the metastatic potential of tumor cells by targeting vacuole membrane protein 1 in hepatocellular carcinoma[J]. Hepatology, 2011, 54(6): 2064-2075.
47. Du R, Sun W, Xia L, et al. Hypoxia-induced down-regulation of microRNA -34a promotes EMT by targeting the Notch signaling pathway in tubular epithelial cells[J]. PLoS One, 2012, 7:e30771.
48. 张栋栋. EMT相关的LncRNA筛选及功能和机制研究[D]. 北京: 北京协和医学院, 2013. ZHANG Dongdong. Study on Screening, Function and Mechanism of EMT-Related LncRNA [D]. Beijing: Peking Union Medical College, 2013.
49. Yuan JH, Yang F, Wang F, et al. A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma[J]. Cancer Cell, 2014, 25(5): 666-681.
50. Yang MH, Wu MZ, Chiou SH, et al. Direct regulation of TWIST by HIF-1alpha promotes metastasis[J]. Nat Cell Biol, 2008, 10(3): 295-305.
51. Sun S, Ning X, Zhang Y, et al. Hypoxia-inducible factor-1alpha induces Twist expression in tubular epithelial cells subjected to hypoxia, leading to epithelial-to-mesenchymal transition[J]. Kidney Int, 2009, 75(12): 1278-1287.
52. Peinado H, Portillo F, Cano A. Switching on-off Snail: LOXL2 versus GSK3beta[J]. Cell Cycle, 2005, 4(12): 1749-1752.
53. Chen J, Imanaka N, Chen J, et al. Hypoxia potentiates Notch signaling in breast cancer leading to decreased E-cadherin expression and increased cell migration and invasion[J]. Br J Cancer, 2010, 102(2): 351-360.
54. Evans AJ, Russell RC, Roche O, et al. VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snail[J]. Mol Cell Biol, 2007, 27(1): 157-169.
55. 纪术峰, 冯志毅, 焦得闯, 等. HIF-1α、PTEN与 VEGF 在乳腺癌组织中的表达及其临床意义[J]. 南方医科大学学报, 2009, 29(8): 1680-1684. JI Shufeng, FENG Zhiyi, JIAO Dechuang, et al. The expression of HIF-1α, PTEN and VEGF in breast cancer and its clinical meaning [J]. Journal of Southern Medical University, 2009, 29(8): 1680-1684.
56. Liang X, Zheng M, Jiang J, et al. Hypoxia-inducible factor-1 alpha, in association with TWIST2 and SNIP1, is a critical prognostic factor in patients with tongue squamous cell carcinoma [J]. Oral Oncol, 2011, 47(2): 92-97.
57. 石燕, 陈丽, 王治宽, 等. I~III期胃癌中 VEGF、HIF-1α 和TGF-β1 表达的临床意义及其预后价值[J]. 临床肿瘤学杂志, 2013, 18(4): 310-316. SHI Yan, CHEN Li, WANG Zhikuan, et al. Clinical and prognostic significances of VEGF, HIF-1α and TGF-β1 expressions for postoperative gastric cancer patients with stage I-III[J]. Chinese Clinical Oncology, 2013,18(4): 310-316.
58. Michieli P. Hypoxia, angiogenesis and cancer therapy: to breathe or not to breathe? [J]. Cell Cycle, 2009, 8(20): 3291-3296.
59. 康强强, 唐敏, 侯妍利, 等. 两性霉素B通过调节 HIF-1α活性抑制缺氧环境下食管癌Eca109 细胞的侵袭迁移能力[J]. 南方医科大学学报, 2014, 34(6): 798-801. KANG Qiangqiang, TANG Min, HOU Yanli, et al. Amphotericin B suppresses migration and invasion of esophageal carcinoma Eca109 cells in hypoxic microenvironment by down-regulating hypoxia-inducible factor-1α activity [J]. Journal of Southern Medical University, 2014, 34(6): 798-801.